Skip to content

Study on the efficacy of Yiqihuoxue Formula combined with individualized aerobic training on patients with coronary heart disease

Study on the efficacy of Yiqihuoxue Formula combined with individualized aerobic training on patients with coronary heart disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000790
Enrollment
Unknown
Registered
2024-12-11
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

Observation Group:On the basis of the control group add the formula of benefiting qi nourishing yin and activating blood.
control group:Individualized aerobic training was used on the basis of conventional drug therapy and the aerobic training protocol was developed based on CPET results.

Sponsors

Changzhou De'an Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Age 40~75 years old; 2.Culture middle school and above; 3.Patients were in the stable stage of disease after chronic stable exertional angina pectoris ischemic cardiomyopathy and acute coronary syndromes including coronary artery disease after asymptomatic myocardial ischemia hemodialysis reconstruction combined with controlled heart failure; 4.Previously no regular exercise habits i.e. <3 times per week and the duration of each exercise <30 min; 5.The patients and their families gave informed consent and voluntarily signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. with severe arrhythmia; 2. with large heart valve disease requiring surgical treatment; 3.myocarditis or pericarditis in the active stage; 4.LVEF Class II; 5. persistent severe angina myocardial infarction or cardiogenic shock; 6.patients with Patients with limb movement disorder; 7.Combined with severe liver kidney brain and other organs failure; 8.New deep vein thrombosis lower limb occlusive atherosclerosis thrombophlebitis aortic dissection and other parts of the aneurysm; 9.Patients with mental disorders; 10.Patients who are taking other traditional Chinese medicines or proprietary Chinese medicine in the course of treatment.

Design outcomes

Primary

MeasureTime frame
Hematology Tests;Cardiopulmonary Reserve Function;Chinese medicine evidence points and clinical efficacy evaluation;

Secondary

MeasureTime frame
sleep quality;Quality of life score;

Countries

China

Contacts

Public ContactLi Jia

Changzhou De'an Hospital

609234006@qq.com+86 159 5057 8729

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026